These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2817021)

  • 1. Calcium carbonate as phosphate binder in patients on low-calcium dialysate.
    Daelemans R; Verhelst JA; Moorkens GH; Zachée P; Lins RL
    Am J Nephrol; 1989; 9(4):348. PubMed ID: 2817021
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium carbonate: a suitable alternative to aluminum hydroxide as phosphate binder.
    Malberti F; Surian M; Colussi G; Poggio F; Minoia C; Salvadeo A
    Kidney Int Suppl; 1988 Mar; 24():S184-5. PubMed ID: 3163047
    [No Abstract]   [Full Text] [Related]  

  • 3. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium carbonate as a phosphate binder in hemodialysis patients.
    Taber TE; Hegemen TF; York S
    ASAIO Trans; 1986; 32(1):127-9. PubMed ID: 3778697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium carbonate as a phosphate binder.
    N Engl J Med; 1987 Jan; 316(2):109-10. PubMed ID: 3785355
    [No Abstract]   [Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of alkaline calcium salts as phosphate binder in uremic patients.
    Fournier A; Morinière P; Ben Hamida F; el Esjer N; Shenovda M; Ghazali A; Bouzernidj M; Achard JM; Westeel PF
    Kidney Int Suppl; 1992 Oct; 38():S50-61. PubMed ID: 1405382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium carbonate is an effective phosphate binder when dialysate calcium concentration is adjusted to control hypercalcemia.
    Mactier RA; Van Stone J; Cox A; Van Stone M; Twardowski Z
    Clin Nephrol; 1987 Nov; 28(5):222-6. PubMed ID: 3427832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium carbonate (CaCO3): an efficient and safe phosphate binder in haemodialysis patients? A 3-year study.
    Sperschneider H; Günther K; Marzoll I; Kirchner E; Stein G
    Nephrol Dial Transplant; 1993; 8(6):530-4. PubMed ID: 8394534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothesis: calcium carbonate as phosphate binder--the fallacy of relying on serum phosphorus.
    Bommer J; Ritz E
    Nephrol Dial Transplant; 2010 May; 25(5):1703-5. PubMed ID: 20179006
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium carbonate. A better phosphate binder than aluminum hydroxide.
    Lerner A; Kramer M; Goldstein S; Caruana R; Epstein S; Raja R
    ASAIO Trans; 1986; 32(1):315-8. PubMed ID: 3535845
    [No Abstract]   [Full Text] [Related]  

  • 12. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder.
    Cheng IK; Lu HB; Chan CY; Cheng SW; Robinson JD; Tam SC; Lo WK; Cheung WC
    Clin Nephrol; 1993 Aug; 40(2):100-5. PubMed ID: 8222365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose calcium carbonate with stepwise reduction in dialysate calcium concentration: effective phosphate control and aluminium avoidance in haemodialysis patients.
    Sawyer N; Noonan K; Altmann P; Marsh F; Cunningham J
    Nephrol Dial Transplant; 1989; 4(2):105-9. PubMed ID: 2496350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sevelamer worsens metabolic acidosis in hemodialysis patients.
    De Santo NG; Frangiosa A; Anastasio P; Marino A; Correale G; Perna A; Di Stazio E; Stellato D; Santoro D; Di Meglio E; Iacono G; Ciacci C; Savica V; Cirillo M
    J Nephrol; 2006; 19 Suppl 9():S108-14. PubMed ID: 16736432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnesium carbonate for phosphate control in patients on hemodialysis. A randomized controlled trial.
    Tzanakis IP; Papadaki AN; Wei M; Kagia S; Spadidakis VV; Kallivretakis NE; Oreopoulos DG
    Int Urol Nephrol; 2008; 40(1):193-201. PubMed ID: 18193489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of parathyroid function after change of phosphate binder from calcium carbonate to lanthanum carbonate in hemodialysis patients with suppressed serum parathyroid hormone.
    Inaba M; Okuno S; Nagayama H; Yamada S; Ishimura E; Imanishi Y; Shoji S
    J Ren Nutr; 2015 Mar; 25(2):242-6. PubMed ID: 25556148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium beta-hydroxy-beta-methylbutyrate. 1. Potential role as a phosphate binder in uremia: in vitro study.
    Sousa MF; Abumrad NN; Martins C; Nissen S; Riella MC
    Nephron; 1996; 72(3):391-4. PubMed ID: 8852485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremia.
    Fournier A; Moriniere P; Sebert JL; Dkhissi H; Atik A; Leflon P; Renaud H; Gueris J; Gregoire I; Idrissi A
    Kidney Int Suppl; 1986 Feb; 18():S114-9. PubMed ID: 3457987
    [No Abstract]   [Full Text] [Related]  

  • 19. CaCO3: an inefficient and unsafe phosphate binder?
    Fournier A; Moriniere P; Hamida FB; Ghazali A
    Nephrol Dial Transplant; 1994; 9(3):335-6. PubMed ID: 8052453
    [No Abstract]   [Full Text] [Related]  

  • 20. Dialysate calcium reduction in CAPD patients treated with calcium carbonate and alfacalcidol.
    Cunningham J; Beer J; Coldwell RD; Noonan K; Sawyer N; Makin HL
    Nephrol Dial Transplant; 1992; 7(1):63-8. PubMed ID: 1316583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.